vs
Side-by-side financial comparison of FIRST MID BANCSHARES, INC. (FMBH) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $88.2M, roughly 1.9× FIRST MID BANCSHARES, INC.). FIRST MID BANCSHARES, INC. runs the higher net margin — 26.8% vs -82.0%, a 108.8% gap on every dollar of revenue. On growth, FIRST MID BANCSHARES, INC. posted the faster year-over-year revenue change (3.4% vs -22.7%). FIRST MID BANCSHARES, INC. produced more free cash flow last quarter ($124.0M vs $-36.6M). Over the past eight quarters, FIRST MID BANCSHARES, INC.'s revenue compounded faster (5.0% CAGR vs -11.5%).
First Mid Bancshares Inc. is a U.S.-headquartered regional financial services holding company. It provides full-range retail and commercial banking products, wealth management, insurance solutions, and agricultural financing, mainly serving individual consumers, small and medium-sized enterprises, and agricultural clients across multiple Midwestern states including Illinois, Missouri, and Indiana.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
FMBH vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $88.2M | $164.7M |
| Net Profit | $23.7M | $-135.0M |
| Gross Margin | — | — |
| Operating Margin | 34.0% | -43.3% |
| Net Margin | 26.8% | -82.0% |
| Revenue YoY | 3.4% | -22.7% |
| Net Profit YoY | 23.5% | -104.8% |
| EPS (diluted) | $0.98 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $88.2M | $164.7M | ||
| Q3 25 | $89.3M | $211.0M | ||
| Q2 25 | $87.5M | $178.9M | ||
| Q1 25 | $84.3M | $1.2B | ||
| Q4 24 | $85.3M | $213.2M | ||
| Q3 24 | $80.6M | $196.8M | ||
| Q2 24 | $79.2M | $186.7M | ||
| Q1 24 | $79.9M | $210.1M |
| Q4 25 | $23.7M | $-135.0M | ||
| Q3 25 | $22.5M | $15.9M | ||
| Q2 25 | $23.4M | $-64.8M | ||
| Q1 25 | $22.2M | $866.6M | ||
| Q4 24 | $19.2M | $-65.9M | ||
| Q3 24 | $19.5M | $-106.7M | ||
| Q2 24 | $19.7M | $-99.2M | ||
| Q1 24 | $20.5M | $-91.6M |
| Q4 25 | 34.0% | -43.3% | ||
| Q3 25 | 32.2% | 1.4% | ||
| Q2 25 | 34.4% | -19.5% | ||
| Q1 25 | 33.4% | 82.5% | ||
| Q4 24 | 29.7% | -76.2% | ||
| Q3 24 | 31.5% | -27.7% | ||
| Q2 24 | 33.7% | -21.5% | ||
| Q1 24 | 33.7% | -21.6% |
| Q4 25 | 26.8% | -82.0% | ||
| Q3 25 | 25.2% | 7.5% | ||
| Q2 25 | 26.8% | -36.3% | ||
| Q1 25 | 26.3% | 73.7% | ||
| Q4 24 | 22.5% | -30.9% | ||
| Q3 24 | 24.2% | -54.2% | ||
| Q2 24 | 24.9% | -53.1% | ||
| Q1 24 | 25.6% | -43.6% |
| Q4 25 | $0.98 | $-1.63 | ||
| Q3 25 | $0.94 | $0.20 | ||
| Q2 25 | $0.98 | $-0.83 | ||
| Q1 25 | $0.93 | $10.04 | ||
| Q4 24 | $0.81 | $-0.85 | ||
| Q3 24 | $0.81 | $-1.39 | ||
| Q2 24 | $0.82 | $-1.29 | ||
| Q1 24 | $0.86 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $1.9B |
| Total DebtLower is stronger | $354.5M | — |
| Stockholders' EquityBook value | $958.7M | $-205.3M |
| Total Assets | $8.0B | $2.9B |
| Debt / EquityLower = less leverage | 0.37× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.9B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $2.0B | ||
| Q1 25 | — | $2.0B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.1B | ||
| Q1 24 | — | $884.8M |
| Q4 25 | $354.5M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $958.7M | $-205.3M | ||
| Q3 25 | $932.2M | $-155.8M | ||
| Q2 25 | $894.1M | $-206.5M | ||
| Q1 25 | $870.9M | $-185.8M | ||
| Q4 24 | $846.4M | $-1.1B | ||
| Q3 24 | $858.5M | $-1.1B | ||
| Q2 24 | $813.6M | $-980.2M | ||
| Q1 24 | $798.0M | $-893.9M |
| Q4 25 | $8.0B | $2.9B | ||
| Q3 25 | $7.8B | $2.6B | ||
| Q2 25 | $7.7B | $2.6B | ||
| Q1 25 | $7.6B | $2.7B | ||
| Q4 24 | $7.5B | $1.7B | ||
| Q3 24 | $7.6B | $1.8B | ||
| Q2 24 | $7.6B | $1.9B | ||
| Q1 24 | $7.7B | $1.8B |
| Q4 25 | 0.37× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $130.9M | $-34.3M |
| Free Cash FlowOCF − Capex | $124.0M | $-36.6M |
| FCF MarginFCF / Revenue | 140.6% | -22.3% |
| Capex IntensityCapex / Revenue | 7.8% | 1.4% |
| Cash ConversionOCF / Net Profit | 5.53× | — |
| TTM Free Cash FlowTrailing 4 quarters | $207.9M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $130.9M | $-34.3M | ||
| Q3 25 | $33.0M | $-66.3M | ||
| Q2 25 | $7.7M | $-58.3M | ||
| Q1 25 | $47.9M | $870.1M | ||
| Q4 24 | $124.4M | $-30.0M | ||
| Q3 24 | $33.1M | $-77.0M | ||
| Q2 24 | $24.0M | $-71.5M | ||
| Q1 24 | $29.0M | $70.8M |
| Q4 25 | $124.0M | $-36.6M | ||
| Q3 25 | $31.9M | $-69.7M | ||
| Q2 25 | $6.0M | $-59.6M | ||
| Q1 25 | $46.0M | $868.4M | ||
| Q4 24 | $119.5M | $-33.8M | ||
| Q3 24 | $32.0M | $-77.5M | ||
| Q2 24 | $22.9M | $-78.8M | ||
| Q1 24 | $27.6M | $61.2M |
| Q4 25 | 140.6% | -22.3% | ||
| Q3 25 | 35.8% | -33.1% | ||
| Q2 25 | 6.8% | -33.3% | ||
| Q1 25 | 54.5% | 73.8% | ||
| Q4 24 | 140.0% | -15.8% | ||
| Q3 24 | 39.7% | -39.4% | ||
| Q2 24 | 28.9% | -42.2% | ||
| Q1 24 | 34.5% | 29.1% |
| Q4 25 | 7.8% | 1.4% | ||
| Q3 25 | 1.2% | 1.6% | ||
| Q2 25 | 2.0% | 0.7% | ||
| Q1 25 | 2.3% | 0.1% | ||
| Q4 24 | 5.8% | 1.8% | ||
| Q3 24 | 1.4% | 0.3% | ||
| Q2 24 | 1.4% | 4.0% | ||
| Q1 24 | 1.9% | 4.6% |
| Q4 25 | 5.53× | — | ||
| Q3 25 | 1.47× | -4.17× | ||
| Q2 25 | 0.33× | — | ||
| Q1 25 | 2.16× | 1.00× | ||
| Q4 24 | 6.49× | — | ||
| Q3 24 | 1.70× | — | ||
| Q2 24 | 1.21× | — | ||
| Q1 24 | 1.42× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.